The difference may be patients’ prolonged exposure to anti-malarial drugs, new research suggests.
Prescribing higher doses of HCQ and adjusting the amount to reach a specific blood level target could help lupus patients avoid blood clots and related complications.
Because of nationwide shortages of hydroxychloroquine (Plaquenil), rheumatology patients are suffering — and some are even scared for their lives.
Rumors are circulating about a study that shows people with lupus don’t get COVID-19, but emerging data says otherwise.
‘Restricting lupus, rheumatoid arthritis, and other rheumatology patients from accessing hydroxychloroquine is wrong.’
‘Hydroxychloroquine is a safe, effective, and inexpensive therapy for conditions like lupus, rheumatoid arthritis. If there is a shortage, it will exacerbate health disparities. People who need an effective and affordable drug won’t be able to get it.’
While not everyone with lupus experiences neuropsychiatric symptoms, new research confirms that many do, especially during the first few years after first being diagnosed.
While lupus and myositis may have some symptoms in common, they are ultimately distinct conditions with very different causes and treatments.
It can sometimes take years to get the right diagnosis of lupus. But knowing what to expect and ask for may speed up the process.
Taking corticosteroid medication plays a role, but it seems that inflammation from the disease itself also affects bone health.